Digital How a new investment is powering a revolution in clinical tr... Clinical trials are the engine for pharmaceutical innovation, but their means of capturing and communicating data are stuck in the past.
News GSK pays $1.2bn for liver drug as it culls TIGIT programme GSK decided to abandon a TIGIT-targeted drug for cancer this week, then hatched a plan to replace it with a candidate for liver disease MASH.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.